Detailed Narrative
Q3 FY26 Performance Overview
NOCIL reported Q3 FY26 revenue of Rs. 316 crores, a slight sequential decline from Rs. 321 crores in Q2 FY26. Operating EBITDA, however, improved to Rs. 27 crores from Rs. 22 crores QoQ, resulting in an EBITDA margin of 8.5%. For the nine months ended December 2025, revenue stood at Rs. 973 crores, down from Rs. 1,053 crores in the prior year, with operating EBITDA at Rs. 80 crores (8.2% margin) compared to Rs. 103 crores.
Domestic vs. International Market Dynamics
Domestic volumes showed high single-digit growth in Q3 FY26, driven by improved demand due to GST 2.0. In contrast, international markets experienced dampened volumes due to seasonal effects and U.S. tariff issues, leading to an 8-9% degrowth in export volumes for the nine-month period. Management anticipates a recovery of approximately 50% of lost U.S. volumes within 2-3 months and expects overall FY26 volumes to grow 3-4%, with FY27 showing double-digit growth.
Antidumping Measures and Trade Agreements
The company has filed antidumping petitions on select key products to counter competitive pricing pressures and dumping from imports. While findings were delayed due to administrative restructuring, conclusions are now expected within the next 1.5-2 months. NOCIL has also initiated a case against Korean antioxidant products. The India-EU FTA, expected to come into play in calendar year 2027, is anticipated to support strategic engagement in European markets.
Capacity Expansion and New Product Development
The TDQ antioxidant investment at Dahej is progressing ahead of schedule, with production trials slated for the first half of calendar year 2026. This expansion, along with new products currently in soft launch, is expected to contribute 10-12% to current volumes, with significant ramp-up anticipated from FY28-29. These initiatives are crucial for future volume growth and market share expansion.
Cost Optimization Initiatives
NOCIL has achieved approximately Rs. 23 crores in conversion cost savings over the nine-month period compared to the previous year. These savings stem from conscious efforts to control working capital, align production with inventory adjustments, and efficient management of utilities. The company aims for a sustained annual improvement of 150 basis points in EBITDA margin over the next 2-4 years through ongoing cost initiatives.
Indian Rubber Chemical Market Overview
The Indian rubber chemical market is estimated to be around 85,000 tons. NOCIL holds a 40% market share (excluding intermediates) or 60% (including intermediates), indicating a significant opportunity for growth through import substitution and leveraging its expanded capacities. The latex segment currently operates at about 60% capacity utilization, providing headroom for future growth.